**Core Concept**
Organophosphorus poisoning is a toxic condition caused by the inhibition of acetylcholinesterase (AChE), an enzyme responsible for breaking down the neurotransmitter acetylcholine (ACh) at the neuromuscular junction. This leads to an accumulation of ACh, resulting in overstimulation of muscarinic and nicotinic receptors.

**Why the Correct Answer is Right**
Organophosphorus poisoning typically presents with features such as excessive salivation, sweating, bradycardia, bronchospasm, and muscle weakness due to the accumulation of ACh. The inhibition of AChE leads to an increase in ACh levels, which in turn activates muscarinic and nicotinic receptors, resulting in the characteristic symptoms of organophosphorus poisoning.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not a feature of organophosphorus poisoning, as the condition is typically associated with increased ACh levels, not decreased levels. Organophosphorus compounds inhibit AChE, leading to an accumulation of ACh, not a deficiency.

**Option B:** This option is incorrect, as organophosphorus poisoning can indeed cause muscle weakness due to the overstimulation of nicotinic receptors at the neuromuscular junction.

**Option C:** This option is incorrect, as organophosphorus poisoning can cause bronchospasm due to the activation of muscarinic receptors in the airways.

**Option D:** This option is incorrect, as organophosphorus poisoning can indeed cause bradycardia due to the activation of muscarinic receptors in the heart.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that organophosphorus poisoning can be treated with atropine, which blocks muscarinic receptors and helps to counteract the effects of excessive ACh. However, atropine does not reverse the inhibition of AChE, and the patient may still require supportive care and possibly pralidoxime to re-activate AChE.

**Correct Answer: A. This option is not a feature of organophosphorus poisoning, as the condition is typically associated with increased ACh levels, not decreased levels.**